HUANG Yu, HU Xin, LI Ziyue, ZHANG Lei
The dominant epitopes from six conserved outer membrane proteins of Neisseria gonorrhoeae (NG) were screeed, multi-epitope subunit vaccines were designed, and the immune responses against them were simulated. Firstly, computer simulation of six outer membrane proteins was performed through the C-ImmSim online server, and the dominant cytotoxic T lymphocyte (CTL) epitopes, helper T (Th) cell epitopes and B cell epitopes were screened from outer membrane proteins with strong CTL, Th cell and B cell immune responses, respectively. Secondly, after the antigenicity, allergenicity, and toxicity analysis of each candidate epitope, candidate epitopes with different arrangement and combinations were connected with antimicrobial peptide and PADRE sequences to construct multi-epitope subunit vaccines. Thirdly, the designed multi-epitope sub-unit vaccines were simulated by computer to evaluate their abilities to induce humoral and cellular immunity. Finally, the candidate subunit vaccines with good immune effect were screened and further evaluated for antigenicity, allergenicity, physicochemical properties, solubility, and secondary structure to ensure that the candidate subunit vaccines meet the vaccine design standards. Through these processes, eight candidate CTL epitopes, 10 Th cell epitopes, and 14 B cell epitopes were selected out, and a total of 64 multi-epitope sub-unit vaccines were designed. Among them, three subunit vaccines had satisfactory immune simulation results, with strong antigenicity, no allergenicity to human body, and no cytotoxicity, were all stable proteins with good hydropathicity and heat resistance, achieved soluble overexpression in E. coli, and had strong affinity with antibodies, all of which met the standards for vaccine design. The results indicated that the bioinfor-matics prediction based mainly on C-ImmSim had a good application prospect in the reverse design of multi-epitope subunit vaccines and high-throughput preliminary screening of their immune effects. This study pro-vided a new and effective approach for the development of N. gonorrhoeae vaccines.